Navegar por autor "Fernández Sueiro, José Luis"

Clinical features of late-onset ankylosing spondylitis: comparison with early-onset disease

2012- Fernández Sueiro, José Luis

Comparacion de 2 estrategias de derivacion en el diagnostico de la espondiloartritis axial en Espana. Estudio RADAR

2013- Fernández Sueiro, José Luis

Comparison of sacroiliac mri evaluation versus sacroiliac X-rays in peripheral psoriatic arthritis: Evidence of silent disease and lack of association to HLA-B27

2012- BLANCO GARCIA, FRANCISCO JAVIER; Pertega Diaz, Sonia; Fernández Sueiro, José Luis; Pinto Tasende, José Antonio

Consenso SER sobre la gestion de riesgo del tratamiento con terapias biologicas en pacientes con enfermedades reumaticas.

2011- Fernández Sueiro, José Luis; Gómez-Reino Carnota, Juan Jesús

Deletion of LCE3C and LCE3B is a susceptibility factor for psoriatic arthritis: A study in Spanish and Italian populations and meta-analysis

2011- Fernández Sueiro, José Luis; Carracedo Álvarez, Ángel

Differences in the Prevalence of Inflammatory Articular Disease in Psoriatic Patients, Applying Clinical, Ultrasound and/or Radiological Data. Implications in the Classification of Psoriatic Arthritis according to Caspar Criteria

2012- Pertega Diaz, Sonia; Fernández Sueiro, José Luis; Pinto Tasende, José Antonio; González Díaz de Rábago, Eugenia

Documento SER de consenso sobre el uso de terapias biologicas en la artritis psoriasica

2011- Fernández Sueiro, José Luis

ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients

2015- Fernández Sueiro, José Luis

Factores pronostico en la artritis psoriasica

2012- Fernández Sueiro, José Luis; Lema Gontad, José Manuel

FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-alpha blockers in psoriatic arthritis: A longitudinal study with 6 months of followup

2012- Fernández Sueiro, José Luis

Fibromyalgia and Enthesitis in Psoriatic Arthritis. Time to “Characterize” and “Refine” Clinical Definitions

2012- Fernández Sueiro, José Luis

High-dose etanercept in ankylosing spondylitis: Results of a 12-week randomized, double blind, controlled multicentre study (LOADET study)

2011- Fernández Sueiro, José Luis

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

2013- Fernández Sueiro, José Luis

Identification of New Epistatic Interactions with the HLA Region in the Genetic Etiology of Psoriasis and Psoriatic Arthritis.

2012- Fernández Sueiro, José Luis

Individual telomere length decay in patients with spondyloarthritis

2014- BLANCO GARCIA, FRANCISCO JAVIER; Pertega Diaz, Sonia; Fernández Sueiro, José Luis; Fernández García, José Luis; Tamayo Novas, María; [et al.]

Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease

2013- Fernández Sueiro, José Luis

Patient global assessment in psoriatic arthritis: A multicenter GRAPPA and OMERACT study

2011- Fernández Sueiro, José Luis

Prevalence of enthesitis in psoriatic patients: Agreement between clinical and power doppler ultrasonography exploration and its implications for the classification of psoriatic arthritis

2012- Pertega Diaz, Sonia; Fernández Sueiro, José Luis; Pinto Tasende, José Antonio

PREVALENCE OF HLA-CW (star)06 AND (star)07 AND ITS RELATIONSHIP WITH PSORIATIC ARTHRITIS IN NORTHWESTERN SPAIN

2013- BLANCO GARCIA, FRANCISCO JAVIER; De Toro Santos, Francisco Javier; Freire Gonzalez, Mercedes; Pertega Diaz, Sonia; Fernández Sueiro, José Luis; [et al.]

Prevalence of hla-drb1 in psoriatic arthritis, psoriasis and rheumatoid arthritis: comparison with healthy controls

2013- BLANCO GARCIA, FRANCISCO JAVIER; De Toro Santos, Francisco Javier; Pertega Diaz, Sonia; Oreiro Villar, Natividad; Fernández Sueiro, José Luis; [et al.]

Repositorio digital RUNA

Navegar por autor "Fernández Sueiro, José Luis"

Clinical features of late-onset ankylosing spondylitis: comparison with early-onset disease ﻿

Comparacion de 2 estrategias de derivacion en el diagnostico de la espondiloartritis axial en Espana. Estudio RADAR ﻿

Comparison of sacroiliac mri evaluation versus sacroiliac X-rays in peripheral psoriatic arthritis: Evidence of silent disease and lack of association to HLA-B27 ﻿

Consenso SER sobre la gestion de riesgo del tratamiento con terapias biologicas en pacientes con enfermedades reumaticas. ﻿

Deletion of LCE3C and LCE3B is a susceptibility factor for psoriatic arthritis: A study in Spanish and Italian populations and meta-analysis ﻿

Differences in the Prevalence of Inflammatory Articular Disease in Psoriatic Patients, Applying Clinical, Ultrasound and/or Radiological Data. Implications in the Classification of Psoriatic Arthritis according to Caspar Criteria ﻿

Documento SER de consenso sobre el uso de terapias biologicas en la artritis psoriasica ﻿

ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients ﻿

Factores pronostico en la artritis psoriasica ﻿

FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-alpha blockers in psoriatic arthritis: A longitudinal study with 6 months of followup ﻿

Fibromyalgia and Enthesitis in Psoriatic Arthritis. Time to “Characterize” and “Refine” Clinical Definitions ﻿

High-dose etanercept in ankylosing spondylitis: Results of a 12-week randomized, double blind, controlled multicentre study (LOADET study) ﻿

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci ﻿

Identification of New Epistatic Interactions with the HLA Region in the Genetic Etiology of Psoriasis and Psoriatic Arthritis. ﻿

Individual telomere length decay in patients with spondyloarthritis ﻿

Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease ﻿

Patient global assessment in psoriatic arthritis: A multicenter GRAPPA and OMERACT study ﻿

Prevalence of enthesitis in psoriatic patients: Agreement between clinical and power doppler ultrasonography exploration and its implications for the classification of psoriatic arthritis ﻿

PREVALENCE OF HLA-CW (star)06 AND (star)07 AND ITS RELATIONSHIP WITH PSORIATIC ARTHRITIS IN NORTHWESTERN SPAIN ﻿

Prevalence of hla-drb1 in psoriatic arthritis, psoriasis and rheumatoid arthritis: comparison with healthy controls ﻿

Clinical features of late-onset ankylosing spondylitis: comparison with early-onset disease

Comparacion de 2 estrategias de derivacion en el diagnostico de la espondiloartritis axial en Espana. Estudio RADAR

Comparison of sacroiliac mri evaluation versus sacroiliac X-rays in peripheral psoriatic arthritis: Evidence of silent disease and lack of association to HLA-B27

Consenso SER sobre la gestion de riesgo del tratamiento con terapias biologicas en pacientes con enfermedades reumaticas.

Deletion of LCE3C and LCE3B is a susceptibility factor for psoriatic arthritis: A study in Spanish and Italian populations and meta-analysis

Differences in the Prevalence of Inflammatory Articular Disease in Psoriatic Patients, Applying Clinical, Ultrasound and/or Radiological Data. Implications in the Classification of Psoriatic Arthritis according to Caspar Criteria

Documento SER de consenso sobre el uso de terapias biologicas en la artritis psoriasica

ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients

Factores pronostico en la artritis psoriasica

FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-alpha blockers in psoriatic arthritis: A longitudinal study with 6 months of followup

Fibromyalgia and Enthesitis in Psoriatic Arthritis. Time to “Characterize” and “Refine” Clinical Definitions

High-dose etanercept in ankylosing spondylitis: Results of a 12-week randomized, double blind, controlled multicentre study (LOADET study)

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

Identification of New Epistatic Interactions with the HLA Region in the Genetic Etiology of Psoriasis and Psoriatic Arthritis.

Individual telomere length decay in patients with spondyloarthritis

Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease

Patient global assessment in psoriatic arthritis: A multicenter GRAPPA and OMERACT study

Prevalence of enthesitis in psoriatic patients: Agreement between clinical and power doppler ultrasonography exploration and its implications for the classification of psoriatic arthritis

PREVALENCE OF HLA-CW (star)06 AND (star)07 AND ITS RELATIONSHIP WITH PSORIATIC ARTHRITIS IN NORTHWESTERN SPAIN

Prevalence of hla-drb1 in psoriatic arthritis, psoriasis and rheumatoid arthritis: comparison with healthy controls